Structure-function of the TNF receptor-like cysteine-rich domain of osteoprotegerin

Molecules and Cells

Volumn 25, Issue 3, 2008, Pages 352-357

  Shin, Joon ^a   Kim, Young Mee ^a   Li, Song Zhe ^b   Lim, Sung Kil ^b   Lee, Weontae ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Bone disease; NMR; OPG analogue peptides; Osteoprotegerin

Indexed keywords

CYCLIC (TYROSYLCYSTYLLEUCYLGLUTAMYLISOLEUCYLGLUTAMYLPHENYLALANYLCYSTYLTYROSINE); OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TYROSYLCYSTYLLEUCYLGLUTAMYLISOLEUCYLGLUTAMYLPHENYLALANYLCYSTYLTYROSINE; UNCLASSIFIED DRUG; COLONY STIMULATING FACTOR 1; CYSTEINE; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; HYDROPHOBICITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSTEOCLAST; OSTEOCLASTOGENESIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; NUCLEAR MAGNETIC RESONANCE; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CELLS, CULTURED; CYSTEINE; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OSTEOCLASTS; OSTEOPROTEGERIN; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RANK LIGAND; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 51049110349     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometskom, E., Roux, E.M., Terpe, M.C., DuBose, R.F., Cosman, D., and Galibert, L. (1997). A homologue of the TNT receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.
2. 1H chemical shifts in proteins. J. Biomol. NMR. 9, 359-369.
3. Chambers, T.J., Owens, J.M., Hattersely, G., Jat, P.S., and Noble, M.D. (1993). Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA 90, 5578-5582.
4. 1H NMR spectra via two-dimmsional homonuclear Hartmann-Hahn spectroscopy. J. Am. Chem. Soc. 107, 2820-2821.
5. Haynes, D.R., Crotti, T.N., Loric, M., Bain, G.I., Atkins, G.J., and Findlay, D.M. (2001). Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology 40, 623-630.
6. Ito, S., Wakabayashi, K., Ubukata, O., Hayashi, S., Okada, F., and Hata, T. (2002). Crystal structure of the extracellular domain of mouse RANK ligand at 2.2 A resolution, J. Biol. Chem. 277, 6631-6636.
7. Jimi, E., Nakamura, I., Amano, H., Taguchi, Y., Tsurukai, T., Tamura, N., and Suda, T. (1996). Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137, 2187-2190.
8. Khosla, S. (2001). Minireview: the OPG/RANKL/RANK systeme. Endocrinology 142, 5050-5055.
9. Koradi, R., Billeter, M., and Wuthrich, K. (1996). MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graphics 14, 51-55.
10. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., and Scully, S. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
11. Lakovski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. (1993). PROCHECK: a program to check the stereochemical quality of proteins structures. J. Appl. Crystallogr. 26, 283-291
12. 1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113, 967-974.
13. Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., and Higashio, K. (1998). RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun. 253, 395-400.
14. Nilges, M., Clore, G.M., and Gronenborn, A.M. (1988a). Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett. 229, 317-324.
15. Nilges, M., Clore, G.M., and Gronenborn, A.M. (1988b). Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. Circumventing problems associated with folding. FEBS Lett. 239, 129-136.
16. Nilges, M., Gronenborn, A.M., Brunger, A.T., and Clore, G.M. (1988c). Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. Protein Eng. 2, 27-38.
17. 1H-NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117, 479-485.
18. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.-S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., and Boone, T. (1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-331.
19. Suda, T., Nakamura, I., Jimi, E., and Takahashi, N. (1997). Role of 1 alpha, 25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol. 282, 223-235.
20. Takasaki, W., Kajino, Y., Kajino, K., Murali, R., and Greene, M.I. (1997). Structure-based design and characterization of exocyclic peptideomimetics that inhibit TNFα binding to its receptor. Nat. Biotech. 15, 1266-1270.
21. Ueland, T., Bollerslev, J., and Mosekilde, L. (2002). Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RANK and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects. Ugeskr Laeger 164, 3526-3530.
22. Wesolowski, G., Duong, L.T., Lakkakorpi, P.T., Nagy, R.M., Tezuka, K., Tanaka, H., Rodan, G.A., and Rodan, S.B. (1995). Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp. Cell Res. 219, 679-686.
23. Whyte, M.P., Obrecht, S.E., Finnegan, P.M., Jones, J.L., Podgornik, M.N., McAlister, W.H., and Mumm, S. (2002). Osteoprotegerin deficiency and juvenile paget's disease. N. Engl. J. Med. 347, 175-184.
24. Wong, B.R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F.S. 3rd., et al. (1997). TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190-25194.
25. Woo, J.T., Kasai, S., Stern, P.H., and Nagai, K. (2000). Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disruqting the actin ring in osteoclasts. J. Bone Miner Res. 15, 650-662.
26. Wüthrich, K. (1986). NMR of protein and nucleic acids. (New York: John Wiley and Sons).
27. Wüthrich, K., Billeten, M., and Braun, W. (1983). Pseudostructures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance. J. Mol. Biol. 169, 949-961.
28. Yamaguchi, K., Kinosaki, M., Goto, M., Kobayashi, F., Morinaga, T., and Higashino, K. (1998). Characterization of structural domains of human osteoclastogenesis inhibitory factor. J. Biol. Chem. 273, 5117-5123.